At a time when Indian hospitals are running low on oxygen and drugs such as Remdesivir, it is imperative to know why this drug is so important in treating critical patients who are COVID-19 positive. Remdesivir is given to patients with a moderate or moderate course to severe infection with COVID-19.

Remdesivir was the first drug approved by the USFDA for the treatment of the SARS-CoV-2 virus. It has been claimed to be effective in severe and critical stages of COVID-19. But, it was also considered “hepatotoxic”, that is to say, damaging liver cells.

According to a WHO study, Remdesivir fails to prevent death in patients, but can reduce the length of hospital stay by 1 to 3 days.

According to experts, this drug should be administered to asymptomatic, mildly symptomatic or seriously ill patients who have suffered from multi-organ dysfunction.

However, it can be used between the second and tenth day of infection to improve its effectiveness in patients with moderate or moderate infection progressing to severe infection.

The doctor explains that the ideal course is six doses over five days (first day 200 mg followed by 100 mg for the next 4 days), and should not be overused.

Meanwhile, officials from the Noida District Health Department said on Thursday that new guidelines had been released regarding the use of Remdesivir.

The guidelines will soon be disseminated to private hospitals as well as to doctors, with the aim of reducing the unnecessary use of Remdesivir and also to curb the black marketing of the drug.

According to the guideline, any hospital prescribing the antiviral drug to a patient will also have to state in writing that they have no doses of the drug in their stockpile if they ask family members to get the vaccine elsewhere, said. officials. .

.